Efficacy of intracavernous etilefrin injections in curative treatment of priapism in sickle-cell patients;Injections intracaverneuses d'etilefrine: Efficacite dans le traitement curatif des episodes de priapisme chez le drepanocytaire

Presse Medicale

Volumn 28, Issue 24, 1999, Pages 1283-1286

  Gbadoe A D ^a   Akakpo Vidah, A ^a   Tsolenyanu E ^a   Messie, K ^a   Atakouma, D Y ^a   Segbena A Y ^a   Vovor, A ^a   Tekou H A ^a   Assimadi, J K ^a  

^a UNIVERSITÉ DE LOMÉ   (Togo)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ETILEFRINE; HEMOGLOBIN S; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ACIDOSIS; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD VISCOSITY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; INTRACAVERNOUS DRUG ADMINISTRATION; MALE; NEUROMUSCULAR DISEASE; PAIN; PRIAPISM; SICKLE CELL ANEMIA; TREATMENT PLANNING; ADOLESCENT; CHILD; DRUG EFFECT; INJECTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ANEMIA, SICKLE CELL; BLOOD VISCOSITY; CHILD; ETILEFRINE; HUMANS; INJECTIONS; MALE; PRIAPISM;

EID: 0033519901     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Emond AM, Holman R, Hayes RJ, Sergeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980; 140:1434-7.
2. Hamre MR, Harmon EP, Kirkpatrick DV, Stern MJ, Humbert JR. Priapism as a complication of sickle cell disease. J Urol 1991 ; 145:1-5.
3. Chakrabarty A, Updhyay J, Dhabuwala CB, Sarnaik S, Perlmutter AD, Connor John P. Priapism associated with sickle cell hemoglobinopathy in children : long-term effects on potency. J Urol 1996 ; 155:1419-23.
4. Nelson JH, Winter CC. Priapism : evolution of management in 48 patients in a 22-year series. J Urol 1977 ; 117:455-8.
5. Ewald DH, Cavender D, Rogers Z. Treatment of severe priapism in young patients with sickle cell disease with oral or intrapenile adrenergic agonists. American Academy of Pediatrics, Section on Urology, Abstract Book, 1994 ; 128:189.
6. Virag R, Bachir D, Lee K, Galacteros F. Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavemous injection of etilefrine. Urology 1996 ; 47:777-81.
7. Virag R, Bachir D, Floresco J, Galactéras F, Dufour B. Traitement ambulatoire et prévention du priapisme par médications alpha-agonistes. À propos de 172 cas. Chirurgie 1996 ; 121:648-53.
8. Brindley GS. New treatment of priapism. Lancet 1984 ; ii:220-1.
9. Serrate RG, Prats J, Regué R, Rius G. The usefulness of etilefrine (Effortil®) in the treatment of priapism and intraoperative penile erections. Int Urol Nephrol 1992 ; 24:389-92.
10. Mulhall J.P, Honig SC. Priapism: etiology and management. Academic emergency medicine 1996 ; 3:810-6.
11. Van Driel MF, Joosten EAHM, Mensink HJA. Intracorporeal self-injection with epinephrine as treatment for idiopathic recurrent priapism. Eur Urol 1990 ; 17:95-6.
12. Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol 1986 ; 135:142-7.
13. Bondil P, Descottes J-L, Salti A, Sabbagh R, Hamza T. Traitement médical du priapisme veineux à propos de 46 cas : ponction, détumescence pharmacologique ou réfrigération pénienne ? Progrés en Urologie 1997 ; 7:433-41.
14. Giuliano F, Rampin O, Bénoit G, Jardin A. Pharmacologie périphérique de l'érection. Progrès en Urologie 1997 ; 7:24-33.
15. Sergeant GR, de Ceulaer K. Stilbestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 1986 ; ii:1274-6.